Archive for July, 2008

Permax and Dostinex

Wednesday, July 30th, 2008

The consumer advocate lawyers at Cappolino Dodd Krebs LLP are reviewing cases involving Permax and Dostinex and their possible link to valvular heart disease (VHD). Typically prescribed for Restless Legs Syndrome (RLS), a recent New England Journal of Medicine study has shown a statistically significant percentage of those who used these drugs for more than one year developed the potentially serious complication of valvular heart disease (VHD).

If you or a loved one has taken Permax or Dostinex and have been harmed by taking it, contact the experienced attorneys at Cappolino Dodd Krebs LLP today, at 1-800-460-0606.

FDA Crackdown Angers Manufacturers

Monday, July 28th, 2008

          It is undeniable that the Food and Drug Administration (FDA) has been tightening its safety strings lately. Last year they approved only 19 new medicines (the lowest number in nearly a quarter century) and put out twice as many new or revised “black-box” warnings for severe side effects as in 2006.
          Whereas consumers may appreciate the FDA’s new burst of caution, drug manufacturers such as Shering-Plough Corp and Merck are pining over lost profits. Company executives are now complaining that it takes longer to get drugs approved now that the FDA is demanding more data, and that even then approval is not guaranteed.
          This crackdown on drug safety has come amid several defective drug scandals, including those of Vioxx, Avandia, Vytorin, Heparin and Chantix. Several of these drugs were approved despite evidence that they may cause serious harm, and others were approved without sufficient testing.

          The defective drug lawyers at Cappolino Dodd Krebs LLP are committed to helping you get compensation you deserve from negligent drug manufacturers when you have been harmed by their products. If you have been harmed by a drug you believe to be dangerous or defective, contact Cappolino Dodd Krebs LLP at 1-800-460-0606 as soon as possible.

New Jersey Ruling on Hormone Replacement Drugs

Monday, July 21st, 2008

In the first three of more than 150 lawsuits over hormone replacement drugs, a New Jersey court has ruled in favor of pharmaceutical giants Wyeth and Pharmacia in cases of deceptive labeling and marketing. Superior Court Judge Jamie Happas heard cases brought by women who took Premarin and Prempro made by Wyeth and Provera by Pharmacia & Upjohn Co.

The women claimed that Wyeth and Pharmacia were guilty of negligence and deception by failing to conduct more studies of the drugs’ side effects before releasing them onto the market. Despite their pleadings, Judge Happas held that while Wyeth and Pharmacia may not have researched as well as they could have, they did all that could be required of them by law.

This sets a shaky precedent for other defective drug lawsuits to follow.

The plaintiffs were taking the hormone replacement pills as therapy for the heat flashes and bone loss of menopause when they developed breast cancer.

At Cappolino Dodd Krebs LLP we are committed to helping you get compensation from negligent drug manufacturers. If you have been harmed by a drug you believe to be dangerous or defective, contact the dangerous drug lawyers at Cappolino Dodd Krebs LLP today, at 1-800-460-0606.